How effective is sitagliptin?

Sitagliptin is an oral drug commonly used to treat type 2 diabetes. Its main function is to increase glucagon (GLP-1) levels by inhibiting dipeptidyl peptidase -4 (DPP-4), thereby regulating blood sugar. Clinical experiments have proven that sitagliptin has significant hypoglycemic effects in both the short and long term, effectively reducing patients' fasting and postprandial blood sugar levels and improving glycated hemoglobin (HbA1c) levels. It is relatively safe, generally well tolerated, and less likely to cause hypoglycemia. For patients with type 2 diabetes, sitagliptin is an effective oral drug that can be used under the guidance of a doctor to maintain stable blood sugar control and improve the patient's quality of life. Patients should follow medical advice when using it and pay close attention to blood sugar changes to ensure the best therapeutic effect.